Viridian Therapeutics, Inc.\DE (VRDN) FCF Margin (QoQ) (2014 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) FCF Margin (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Viridian Therapeutics, Inc.\DE | 229.55 Mn | 229.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.67 Mn |
| Dec 31, 2025 | -1.81 Mn |
| Sep 30, 2025 | 10.04 Mn |
| Jun 30, 2025 | 2.83 Mn |
| Mar 31, 2025 | -2.68 Mn |
| Dec 31, 2024 | -2.29 Mn |
| Sep 30, 2024 | -1.50 Mn |
| Jun 30, 2024 | -130,417.00 |
| Mar 31, 2024 | -996,528.00 |
| Dec 31, 2023 | 185,972.00 |
| Sep 30, 2023 | 855,278.00 |
| Jun 30, 2023 | 9,816.00 |
| Mar 31, 2023 | -3.11 Mn |
| Dec 31, 2022 | -3.05 Mn |
| Sep 30, 2022 | 521,802.00 |
| Jun 30, 2022 | 282,962.00 |
| Mar 31, 2022 | -221,472.00 |
| Dec 31, 2021 | -181,126.00 |
| Sep 30, 2021 | -444,993.00 |
| Jun 30, 2021 | -55,338.00 |